Dehydroglyasperin D Suppresses Melanin Synthesis through MITF Degradation in Melanocytes

키워드

참고문헌 (33)

1. Kobayashi N, "Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis", J. Investig. Dermatol, 110, pp.806~810 (1998)
2. Briganti S, "Chemical and instrumental approaches to treat hyperpigmentation", Pigment Cell Res, 16, pp.101~110 (2003)
3. Wenczl E, "(Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytes", J. Investig. Dermatol, 111, pp.678~682 (1998)
4. Kobayashi T, "Tyrosinase related protein 1(TRP1)functions as a DHICA oxidase in melanin biosynthesis", EMBO J, 13, pp.5818~5825 (1994)
5. Ando H, "Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis", J. Lipid Res, 40, pp.1312~1316 (1999)
6. Solano F, "Hypopigmenting agents : an updated review on biological, chemical and clinical aspects", Pigment Cell Res, 19, pp.550~571 (2006)
7. Yamaguchi Y, "Physiological factors that regulate skin pigmentation", Biofactors, 35, pp.193~199 (2009)
8. Goding CR, "Mitf from neural crest to melanoma : signal transduction and transcription in the melanocyte lineage", Genes Dev, 14, pp.1712~1728 (2000)
9. Shibahara S, "Microphthalmia-associated transcription factor(MITF) : multiplicity in structure, function, and regulation", J. Investig. Dermatol. Symp. Proc, 6, pp.99~104 (2001)
10. Khaled M, "Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis", J. Biol. Chem, 277, pp.33690~33697 (2002)
11. Busca R, "Inhibition of the phosphatidylinositol 3-kinase", p70S6-kinase pathway induces B16 melanoma cell differentiation, 1996, pp.271, 31824~31830
12. Oka M, "Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells", J. Investig. Dermatol, 115, pp.699~703 (2000)
13. Shibata S, "A drug over the millennia : pharmacognosy, chemistry, and pharmacology of licorice", Yakugaku zasshi, 120, pp.849~862 (2000)
14. Fiore C, "A history of the therapeutic use of liquorice in Europe", J. Ethnopharmacol, 99, pp.317~324 (2005)
15. Zhu WY, "The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders", J. Invest. Dermatol. Symp. Proc, 13, pp.20~24 (2008)
16. Kim HJ, "Identification of tyrosinase inhibitors from Glycyrrhiza uralensis", Planta Med, 71, pp.785~787 (2005)
17. Fu B, "Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase", J. Agric. Food Chem, 53, pp.7408~7414 (2005)
18. Yokota T, "The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation", Pigment Cell Res, 11, pp.355~361 (1998)
19. Seo JY, "Dehydroglyasperin C isolated from licorice caused Nrf2-mediated induction of detoxifying enzymes", J. Agric. Food Chem, 58, pp.1603~1608 (2010)
20. Mae T, "A licorice ethanolic extract with peroxisome proliferator-activated receptor-gamma ligand-binding activity affects diabetes in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats", J. Nutr, 133, pp.3369~3377 (2003)
21. Kuroda M, "Phenolics with PPAR-gamma ligand-binding activity obtained from licorice(Glycyrrhiza uralensis roots)and ameliorative effects of glycyrin on genetically diabetic KK-A(y)mice", Bioorg. Med. Chem. Lett, 13, pp.4267~4272 (2003)
22. Li J, "Isoangustone A suppresses mesangial fibrosis and inflammation in human renal mesangial cells", Exp. Biol. Med, 236, pp.435~444 (2011)
23. Seon MR, "Isoangustone A present in hexane", ethanol extract of Glycyrrhiza uralensis induces apoptosis in DU145 human prostate cancer cells via the activation of DR4 and intrinsic apoptosis pathway, 2010, pp.54, 1329~1339
24. Park S, "Anti-melanogenic effects of resveratryl triglycolate, a novel hybrid compound derived by esterification of resveratrol with glycolic acid", Arch. Dermatol. Res, 308, pp.325~334 (2016)
25. An SM, "p-coumaric acid, a constituent of Sasa quelpaertensis Nakai, inhibits cellular melanogenesis stimulated by alpha-melanocyte stimulating hormone", Br. J. Dermatol, 159, pp.292~299 (2008)
26. Goding CR, "Regulation of melanocyte differentiation and growth", Cell Growth Differ, 8, pp.935~940 (1997)
27. Sato S, "CBP", p300 as a co-factor for the Microphthalmia transcription factor, 1997, pp.14, 3083~3092
28. Yasumoto K, "Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes", J. Biol. Chem, 272, pp.503~509 (1997)
29. Steingrimsson E, "Melanocytes and the microphthalmia transcription factor network", Ann. Rev. Genet, 38, pp.365~411 (2004)
30. Englaro W, "Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells", J. Biol. Chem, 270, pp.24315~24320 (1995)
31. Bertolotto C, "In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter", Oncogene, 16, pp.1665~1670 (1998)
32. Wu M, "c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi", Genes Dev, 14, pp.301~312 (2000)
33. Xu W, "Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9", Exp. Cell Res, 255, pp.135~143 (2000)

관련 논문AI추천